CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...